By Counterforce Health Team in Kesimpta (ofatumumab) —

How to Get Kesimpta (Ofatumumab) Covered by Blue Cross Blue Shield in Georgia: Prior Authorization, Appeals, and State Law Protections

Answer Box: Getting Kesimpta Covered by Blue Cross Blue Shield in Georgia

Kesimpta (ofatumumab) requires prior authorization from Blue Cross Blue Shield Georgia and is typically classified as a specialty medication. The fastest path to approval: 1) Have your neurologist submit a prior authorization with complete MS diagnosis documentation and evidence of prior DMT failures or contraindications, 2) If denied, file an internal appeal within 60 days, and 3) Request external review with the Georgia Department of Insurance within 60 days of final denial. Georgia law mandates step therapy exceptions for MS medications when clinically justified.

First step today: Call BCBS member services (number on your insurance card) to verify your specific plan's formulary tier for Kesimpta and request the prior authorization form.

Table of Contents

Why Georgia State Rules Matter for MS Medications

Georgia's insurance laws provide important protections for multiple sclerosis patients that go beyond what your Blue Cross Blue Shield plan might voluntarily offer. These state-mandated protections interact with your plan's policies to create additional avenues for coverage when standard prior authorization is denied.

Key Georgia protections include:

  • Mandatory step therapy exceptions for MS disease-modifying therapies (DMTs) when clinically justified
  • 24-hour turnaround for urgent step therapy override requests
  • External review rights through the Georgia Department of Insurance
  • Continuity of care provisions during plan transitions

Understanding these rights is crucial because BCBS Georgia must comply with state law even when their standard formulary policies might be more restrictive.

Note: These protections apply to fully insured plans. Self-funded employer plans (covered under ERISA) may have different rules, though many voluntarily follow similar standards.

Prior Authorization Requirements and Turnaround Standards

Coverage at a Glance

Requirement What It Means Timeline Source
Prior Authorization Required before dispensing 2-14 business days BCBS Georgia Formulary
Specialty Pharmacy Must use in-network specialty pharmacy N/A Plan documents
Neurologist Documentation Diagnosis, prior treatments, medical necessity With PA submission Clinical criteria
Step Therapy May require trial of preferred DMTs first Override available Georgia Code § 33-24-59.25

Step-by-Step: Fastest Path to Approval

  1. Verify Coverage (Patient/Clinic): Call BCBS member services to confirm Kesimpta's formulary tier and specific prior authorization requirements for your plan.
  2. Gather Documentation (Clinic): Collect MS diagnosis confirmation, MRI results, prior DMT trials and outcomes, contraindications to preferred therapies, and current clinical status.
  3. Submit Prior Authorization (Prescriber): Complete BCBS prior authorization form through provider portal or CoverMyMeds, including all supporting documentation.
  4. Follow Up (Clinic): Track submission status and respond promptly to any requests for additional information.
  5. If Denied, File Internal Appeal (Patient/Prescriber): Submit within 60 days with additional clinical justification and evidence.
  6. Request External Review if Needed (Patient): File with Georgia DOI within 60 days of final internal denial.
  7. Utilize Manufacturer Support (Patient): Contact Novartis Kesimpta support for bridge therapy during appeals.

Step Therapy Protections Under Georgia Law

Georgia law provides strong protections against inappropriate step therapy requirements for MS medications. Under Georgia Code § 33-24-59.25, BCBS must grant a step therapy exception when your provider demonstrates:

Automatic Override Criteria:

  • The required (preferred) DMT is contraindicated or likely to cause serious harm
  • The required DMT is expected to be ineffective for your specific clinical condition
  • You previously tried and failed the required DMT or a drug in the same class
  • You're stable on your current DMT and switching would be harmful or ineffective

Timeline Requirements:

  • Urgent requests: 24-hour decision deadline
  • Routine requests: 2 business days maximum
  • Drug samples do not count as adequate trials

Clinician Corner: Medical Necessity Documentation

When requesting a step therapy exception, include these elements in your clinical documentation:

Essential Components:

  • Confirmed MS diagnosis with phenotype (RRMS, SPMS, CIS)
  • MRI findings supporting relapsing disease activity
  • Detailed history of prior DMT trials, including:
    • Specific medications tried
    • Duration of each trial
    • Reasons for discontinuation (efficacy failure, adverse events, contraindications)
  • Current clinical status and treatment goals
  • Rationale for Kesimpta selection over formulary alternatives

Supporting Evidence:

  • Reference FDA labeling for Kesimpta's approved indications
  • Cite relevant treatment guidelines (American Academy of Neurology, ECTRIMS/EAN)
  • Include contraindication documentation for preferred therapies

Continuity of Care and Transition Coverage

Blue Cross Blue Shield Georgia typically provides transition coverage when you switch plans or when formulary changes affect your current therapy. This continuity of care provision ensures you don't lose access to essential MS medications abruptly.

Transition Coverage Details:

  • Duration: Usually 30 days for retail medications, one fill for specialty drugs
  • Eligibility: New members or existing members affected by formulary changes
  • Requirements: Must be actively using the medication for a chronic condition like MS

Next Steps During Transition:

  1. Contact your prescriber immediately to initiate prior authorization for long-term coverage
  2. Work with your specialty pharmacy to coordinate the transition fill
  3. Submit any required formulary exception requests with clinical justification

For ongoing coverage beyond the transition period, you'll need to complete the standard prior authorization process or secure a formulary exception.

Appeals Process: Internal and External Review

Internal Appeals with BCBS Georgia

Timeline: Must file within 60 days of denial notice Decision deadline:

  • Standard: 30 days for pre-service, 60 days for post-service
  • Expedited: 72 hours for urgent situations

Required documentation:

  • Original denial letter and explanation of benefits (EOB)
  • Additional clinical documentation supporting medical necessity
  • Provider letter explaining why Kesimpta is appropriate for your specific case

External Review Through Georgia Department of Insurance

If your internal appeal is denied, you have the right to external review by an independent organization.

Key Details:

  • Filing deadline: 60 days from final internal denial
  • Cost: Free to patients
  • Decision timeline: 45 days (72 hours for expedited)
  • Binding decision: BCBS must comply if review supports coverage

How to File:

  1. Complete external review application from Georgia DOI website
  2. Include all denial letters and supporting medical documentation
  3. Submit via online portal, mail, or fax to Georgia Department of Insurance

Success rates: National data shows approximately 40-50% of external reviews overturn insurer denials, making this a valuable option for wrongfully denied coverage.

Common Denial Reasons and How to Fix Them

Denial Reason How to Overturn Documentation Needed
"Not relapsing MS phenotype" Provide MRI evidence of active lesions Recent MRI reports, neurologist assessment
"Missing baseline labs/vaccinations" Complete required testing HBV screening, vaccination records, CBC
"Must try preferred DMT first" Request step therapy exception Prior trial documentation, contraindication evidence
"Quantity limits exceeded" Justify dosing regimen FDA labeling, weight-based calculations
"Not medically necessary" Comprehensive clinical justification Treatment history, current status, prognosis

Practical Scripts for Patients and Providers

Patient Phone Script for BCBS Member Services

"Hi, I'm calling about prior authorization for Kesimpta, generic name ofatumumab, for multiple sclerosis. My member ID is [ID number]. Can you tell me the specific prior authorization requirements for my plan and provide the forms my doctor needs? I'd also like to know if there are step therapy requirements and how to request an exception under Georgia law if needed."

Clinic Staff Script for Peer-to-Peer Review

"We're requesting a peer-to-peer review for Kesimpta prior authorization denial. The patient has relapsing MS with documented disease activity despite prior DMT trials. We have clinical documentation showing contraindications to your preferred alternatives and evidence supporting Kesimpta's medical necessity for this specific case."

Cost Assistance and Support Programs

Manufacturer Support:

State and Foundation Programs:

  • Georgia residents may qualify for assistance through national MS organizations
  • Check eligibility for pharmaceutical company patient assistance programs

Specialty Pharmacy Support:

  • Many specialty pharmacies offer dedicated coverage advocates to help navigate prior authorization and appeals
From our advocates: We've seen patients successfully overturn initial denials by providing comprehensive documentation of prior DMT failures and contraindications to preferred alternatives. The key is thorough clinical documentation and persistence through the appeals process – many cases are approved on internal appeal when the complete clinical picture is presented clearly.

When to Contact Georgia Insurance Regulators

Contact the Georgia Department of Insurance Consumer Services if:

  • BCBS fails to respond to appeals within required timeframes
  • You need help understanding your external review rights
  • You encounter procedural barriers to filing appeals

Georgia DOI Consumer Services:

  • Phone: 1-800-656-2298
  • Online: Consumer complaint portal
  • They can provide guidance and ensure proper processing of external review requests

For complex cases, consider contacting Georgians for a Healthy Future, a nonprofit that assists consumers with insurance appeals and can provide referrals to legal assistance when needed.

Frequently Asked Questions

How long does BCBS prior authorization take in Georgia? Standard prior authorizations typically take 2-14 business days. Expedited requests for urgent medical situations must be decided within 72 hours under both state and federal requirements.

What if Kesimpta isn't on my BCBS formulary? You can request a formulary exception with clinical justification. Georgia law requires consideration of medical necessity even for non-formulary medications when clinically appropriate.

Can I get expedited appeals for MS medications? Yes, if delaying treatment would seriously jeopardize your health or ability to regain maximum function. Document the urgency with your neurologist's assessment.

Do step therapy requirements apply if I failed DMTs with previous insurance? Georgia law recognizes prior failures from any health plan, not just your current one. Provide documentation of previous trials and outcomes.

What happens if I'm stable on Kesimpta and my plan changes? Continuity of care provisions typically provide transition coverage while you complete prior authorization for the new plan. Georgia law also protects against harmful switches when you're stable on current therapy.

How do I prove medical necessity for Kesimpta? Work with your neurologist to document your MS diagnosis, disease activity, prior treatment failures or contraindications, and why Kesimpta is specifically appropriate for your case.

What if my employer plan is self-funded? Self-funded ERISA plans may not be subject to all Georgia state protections, but many follow similar standards. Check your plan documents or contact HR for specific appeal procedures.

Can I continue Kesimpta during the appeals process? Novartis offers bridge therapy programs for eligible patients. Your specialty pharmacy may also provide temporary supplies in certain circumstances.

Counterforce Health helps patients, clinicians, and specialty pharmacies navigate complex prior authorization and appeals processes for medications like Kesimpta. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that address specific coverage criteria. By identifying the exact reasons for denial and crafting point-by-point rebuttals using appropriate clinical evidence and payer-specific workflows, we help turn insurance denials into approvals. Learn more about our coverage support services at www.counterforcehealth.org.

When facing a Kesimpta denial from Blue Cross Blue Shield in Georgia, remember that you have multiple avenues for appeal, including strong state law protections for MS patients. The combination of thorough clinical documentation, understanding of your plan's specific requirements, and persistence through the appeals process often leads to successful coverage. Tools like Counterforce Health can help streamline this process by ensuring your appeals are properly structured and evidence-based, increasing your chances of approval.

Sources & Further Reading

This article is for informational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about treatment decisions and contact qualified legal counsel for specific legal questions. Coverage policies and state regulations may change; verify current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.